Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

STAAR Surgical Co (NASDAQ:STAA)

9.40
Delayed Data
As of Sep 30
 +0.24 / +2.62%
Today’s Change
4.98
Today|||52-Week Range
9.78
+31.65%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$380.1M

Company Description

STAAR Surgical Co. engages in the development, manufacture, and trade of implantable lenses for the eye. Its products include intraocular lens (""IOL"") and implantable collamer lens (""ICL"") which targets the following eye conditions: myopia, astigmatism, hyperopia, and cataracts. It distributes under the following trademarks: Collamer IOLs, Preloaded IOLs, EVO Visian ICL, EVO+ Visian ICL, and Visian ICL. The company was founded in 1982 and is headquartered in Monrovia, CA.

Contact Information

STAAR Surgical Co.
1911 Walker Avenue
Monrovia California 91016
P:(626) 303-7902
Investor Relations:
(415) 652-9100

Employees

Shareholders

Other institutional47.53%
Individual stakeholders30.18%
Mutual fund holders27.80%

Top Executives

Caren L. MasonPresident, Chief Executive Officer & Director
Graydon HansenVice President-Operations
Stephen P. BrownChief Financial Officer & Vice President
Jon K. HayashidaVice President-Medical Affairs & Global Clinical
Keith HollidayVice President-Research & Development